164
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Electrocardiographic abnormalities and NT-proBNP levels at long-term follow-up of patients with dyspnea after pulmonary embolism

, , , &
Article: 2373090 | Received 30 Sep 2023, Accepted 22 Jun 2024, Published online: 03 Jul 2024

References

  • Elias A, Mallett S, Daoud-Elias M, et al. Prognostic models in acute pulmonary embolism: a systematic review and meta-analysis. BMJ Open. 2016;6(4):e010324. doi: 10.1136/bmjopen-2015-010324.
  • Vedovati MC, Germini F, Agnelli G, et al. Prognostic role of embolic burden assessed at computed tomography angiography in patients with acute pulmonary embolism: systematic review and meta-analysis. J Thromb Haemost. 2013;11(12):2092–2102. doi: 10.1111/jth.12429.
  • Qaddoura A, Digby GC, Kabali C, et al. The value of electrocardiography in prognosticating clinical deterioration and mortality in acute pulmonary embolism: a systematic review and meta-analysis. Clin Cardiol. 2017;40(10):814–824. doi: 10.1002/clc.22742.
  • El-Menyar A, Sathian B, Al-Thani H. Elevated serum cardiac troponin and mortality in acute pulmonary embolism: systematic review and meta-analysis. Respir Med. 2019;157:26–35. doi: 10.1016/j.rmed.2019.08.011.
  • Prosperi-Porta G, Ronksley P, Kiamanesh O, et al. Prognostic value of echocardiography-derived right ventricular dysfunction in haemodynamically stable pulmonary embolism: a systematic review and meta-analysis. Eur Respir Rev. 2022;31(166):220120. doi: 10.1183/16000617.0120-2022.
  • Sista AK, Klok FA. Late outcomes of pulmonary embolism: the post-PE syndrome. Thromb Res. 2017;164:157–162. doi: 10.1016/j.thromres.2017.06.017.
  • Alblas H, van Kan C, van Het Westeinde SC, et al. Persistent dyspnea after acute pulmonary embolism is related to perfusion defects and lower long-term quality of life. Thromb Res. 2022;219:89–94. doi: 10.1016/j.thromres.2022.09.008.
  • Yuriditsky E, Horowitz JM, Lau JF. Chronic thromboembolic pulmonary hypertension and the post-pulmonary embolism (PE) syndrome. Vasc Med. 2023;28(4):348–360. doi: 10.1177/1358863X231165105.
  • Klok FA, van Kralingen KW, van Dijk APJ, et al. Prevalence and potential determinants of exertional dyspnea after acute pulmonary embolism. Respir Med. 2010;104(11):1744–1749. doi: 10.1016/j.rmed.2010.06.006.
  • Nilsson LT, Andersson T, Larsen F, et al. Dyspnea after pulmonary embolism: a nation-wide population-based case-control study. Pulm Circ. 2021;11(4):20458940211046831. doi: 10.1177/20458940211046831.
  • van der Meer RW, Pattynama PMT, van Strijen MJL, et al. Right ventricular dysfunction and pulmonary obstruction index at helical CT: prediction of clinical outcome during 3-month follow-up in patients with acute pulmonary embolism. Radiology. 2005;235(3):798–803. doi: 10.1148/radiol.2353040593.
  • Konstantinides SV, Vicaut E, Danays T, et al. Impact of thrombolytic therapy on the long-term outcome of intermediate-risk pulmonary embolism. J Am Coll Cardiol. 2017;69(12):1536–1544. doi: 10.1016/j.jacc.2016.12.039.
  • Vanni S, Polidori G, Vergara R, et al. Prognostic value of ECG among patients with acute pulmonary embolism and normal blood pressure. Am J Med. 2009;122(3):257–264. doi: 10.1016/j.amjmed.2008.08.031.
  • Henzler T, Roeger S, Meyer M, et al. Pulmonary embolism: CT signs and cardiac biomarkers for predicting right ventricular dysfunction. Eur Respir J. 2012;39(4):919–926. doi: 10.1183/09031936.00088711.
  • Reesink HJ, Tulevski II, Marcus JT, et al. Brain natriuretic peptide as noninvasive marker of the severity of right ventricular dysfunction in chronic thromboembolic pulmonary hypertension. Ann Thorac Surg. 2007;84(2):537–543. doi: 10.1016/j.athoracsur.2007.04.006.
  • Gutte H, Mortensen J, Jensen CV, et al. ANP, BNP and D-dimer predict right ventricular dysfunction in patients with acute pulmonary embolism. Clin Physiol Funct Imaging. 2010;30(6):466–472. doi: 10.1111/j.1475-097X.2010.00967.x.
  • Yardan T, Altintop L, Baydin A, et al. B-type natriuretic peptide as an indicator of right ventricular dysfunction in acute pulmonary embolism. Int J Clin Pract. 2008;62(8):1177–1182. doi: 10.1111/j.1742-1241.2007.01380.x.
  • Cavallazzi R, Nair A, Vasu T, et al. Natriuretic peptides in acute pulmonary embolism: a systematic review. Intensive Care Med. 2008;34(12):2147–2156. doi: 10.1007/s00134-008-1214-5.
  • Ohigashi H, Haraguchi G, Yoshikawa S, et al. Comparison of biomarkers for predicting disease severity and long-term respiratory prognosis in patients with acute pulmonary embolism. Int Heart J. 2010;51(6):416–420. doi: 10.1536/ihj.51.416.
  • Nithianandan H, Reilly A, Tritschler T, et al. Applying rigorous eligibility criteria to studies evaluating prognostic utility of serum biomarkers in pulmonary embolism: a systematic review and meta-analysis. Thromb Res. 2020;195:195–208. doi: 10.1016/j.thromres.2020.07.037.
  • Bolt L, Lauber S, Limacher A, et al. Prognostic value of electrocardiography in elderly patients with acute pulmonary embolism. Am J Med. 2019;132(12):e835–e43. doi: 10.1016/j.amjmed.2019.05.041.
  • Thomson D, Kourounis G, Trenear R, et al. ECG in suspected pulmonary embolism. Postgrad Med J. 2019;95(1119):12–17. doi: 10.1136/postgradmedj-2018-136178.
  • Digby GC, Kukla P, Zhan Z-Q, et al. The value of electrocardiographic abnormalities in the prognosis of pulmonary embolism: a consensus paper. Ann Noninvasive Electrocardiol. 2015;20(3):207–223. doi: 10.1111/anec.12278.
  • Boon GJAM, Ende-Verhaar YM, Bavalia R, et al. Non-invasive early exclusion of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the InShape II study. Thorax. 2021;76(10):1002–1009. doi: 10.1136/thoraxjnl-2020-216324.
  • Klok FA, Surie S, Kempf T, et al. A simple non-invasive diagnostic algorithm for ruling out chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. Thromb Res. 2011;128(1):21–26. doi: 10.1016/j.thromres.2011.03.004.
  • Bonderman D, Wexberg P, Martischnig AM, et al. A noninvasive algorithm to exclude pre-capillary pulmonary hypertension. Eur Respir J. 2011;37(5):1096–1103. doi: 10.1183/09031936.00089610.
  • Kim NH, Lang IM. Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2012;21(123):27–31. doi: 10.1183/09059180.00009111.
  • Blackburn H, Keys A, Simonson E, et al. The electrocardiogram in population studies. A classification system. Circulation. 1960;21(6):1160–1175. doi: 10.1161/01.cir.21.6.1160.
  • Surawicz B, Childers R, Deal BJ, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol. 2009;53(11):976–981. doi: 10.1016/j.jacc.2008.12.013.
  • Rautaharju PM, Surawicz B, Gettes LS, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology. Circulation. 2009;119(10):e241-50–e250. doi: 10.1161/CIRCULATIONAHA.108.191096.
  • Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction. Circulation. 2007;116(22):2634–2653. doi: 10.1161/CIRCULATIONAHA.107.187397.
  • Sandler LL, Pinnow EE, Lindsay J. The accuracy of electrocardiographic Q waves for the detection of prior myocardial infarction as assessed by a novel standard of reference. Clin Cardiol. 2004;27(2):97–100. doi: 10.1002/clc.4960270212.
  • Punukollu G, Gowda RM, Vasavada BC, et al. Role of electrocardiography in identifying right ventricular dysfunction in acute pulmonary embolism. Am J Cardiol. 2005;96(3):450–452. doi: 10.1016/j.amjcard.2005.03.099.
  • Mueller C, McDonald K, de Boer RA, et al. Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations. Eur J Heart Fail. 2019;21(6):715–731. doi: 10.1002/ejhf.1494.
  • Casazza F, Pacchetti I, Rulli E, et al. Prognostic significance of electrocardiogram at presentation in patients with pulmonary embolism of different severity. Thromb Res. 2018;163:123–127. doi: 10.1016/j.thromres.2018.01.025.
  • Alventosa-Zaidin M, Guix Font L, Benitez Camps M, et al. Right bundle branch block: prevalence, incidence, and cardiovascular morbidity and mortality in the general population. Eur J Gen Pract. 2019;25(3):109–115. doi: 10.1080/13814788.2019.1639667.
  • Svennberg E, Engdahl J, Al-Khalili F, et al. Mass screening for untreated atrial fibrillation. Circulation. 2015;131(25):2176–2184. doi: 10.1161/CIRCULATIONAHA.114.014343.
  • Klok FA, van der Hulle T, den Exter PL, et al. The post-PE syndrome: a new concept for chronic complications of pulmonary embolism. Blood Rev. 2014;28(6):221–226. doi: 10.1016/j.blre.2014.07.003.
  • van Kan C, van der Plas MN, Reesink HJ, et al. Hemodynamic and ventilatory responses during exercise in chronic thromboembolic disease. J Thorac Cardiovasc Surg. 2016;152(3):763–771. doi: 10.1016/j.jtcvs.2016.05.058.
  • Capone C, Valentini A, Spinillo SL, et al. Radiological differences between chronic thromboembolic pulmonary disease (CTEPD) and chronic thromboembolic pulmonary hypertension (CTEPH). Eur Radiol. 2021;31(8):6230–6238. doi: 10.1007/s00330-020-07556-4.
  • Morrison LK, Harrison A, Krishnaswamy P, et al. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol. 2002;39(2):202–209. doi: 10.1016/s0735-1097(01)01744-2.